PL3634444T3 - Kompozycje do zastosowania w leczeniu Helicobacter pylori - Google Patents

Kompozycje do zastosowania w leczeniu Helicobacter pylori

Info

Publication number
PL3634444T3
PL3634444T3 PL18813845.7T PL18813845T PL3634444T3 PL 3634444 T3 PL3634444 T3 PL 3634444T3 PL 18813845 T PL18813845 T PL 18813845T PL 3634444 T3 PL3634444 T3 PL 3634444T3
Authority
PL
Poland
Prior art keywords
compositions
treatment
helicobacter pylori
pylori
helicobacter
Prior art date
Application number
PL18813845.7T
Other languages
English (en)
Inventor
Muhammed Majeed
Kalyanam Nagabhushanam
Sivakumar Arumugam
Furqan Ali
Shaheen Majeed
Original Assignee
Sami-Sabinsa Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami-Sabinsa Group Limited filed Critical Sami-Sabinsa Group Limited
Publication of PL3634444T3 publication Critical patent/PL3634444T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18813845.7T 2017-06-06 2018-06-06 Kompozycje do zastosowania w leczeniu Helicobacter pylori PL3634444T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762516066P 2017-06-06 2017-06-06
PCT/US2018/036192 WO2018226781A1 (en) 2017-06-06 2018-06-06 Compositions for management of helicobacter pylori infections

Publications (1)

Publication Number Publication Date
PL3634444T3 true PL3634444T3 (pl) 2024-03-04

Family

ID=64458548

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18813845.7T PL3634444T3 (pl) 2017-06-06 2018-06-06 Kompozycje do zastosowania w leczeniu Helicobacter pylori

Country Status (9)

Country Link
US (1) US10792295B2 (pl)
EP (1) EP3634444B1 (pl)
JP (1) JP6839329B2 (pl)
KR (1) KR102403453B1 (pl)
AU (1) AU2018281141B2 (pl)
CA (1) CA3061613C (pl)
ES (1) ES2963171T3 (pl)
PL (1) PL3634444T3 (pl)
WO (1) WO2018226781A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6922256B2 (ja) 2017-02-28 2021-08-18 ブラザー工業株式会社 液体供給装置及び画像記録装置
US11117382B2 (en) 2017-02-28 2021-09-14 Brother Kogyo Kabushiki Kaisha Liquid supplying device having tank and cartridge attachable thereto
US11413318B2 (en) * 2017-06-06 2022-08-16 Sami-Sabinsa Group Limited Compositions and methods for management of atrophic gastritis and colitis
TWI757850B (zh) * 2019-08-27 2022-03-11 大江生醫股份有限公司 唾液乳桿菌tci153及唾液乳桿菌tci153及/或其破菌液在製備改善肌膚狀況的組合物之用途
CN114686396A (zh) * 2021-12-23 2022-07-01 微康益生菌(苏州)股份有限公司 一种抗幽门螺杆菌的凝结芽孢杆菌bc99及其应用
KR20240084959A (ko) 2022-12-07 2024-06-14 정현철 위장질환에 효과가 있는 효소액의 제조방법 및 이에 따라 제조된 효소액
CN121177462A (zh) * 2023-01-13 2025-12-23 海图生物科技(上海)有限责任公司 一种高效根除幽门螺杆菌的药物组合物及其制备方法和其应用
CN118562689B (zh) * 2024-08-05 2024-11-22 杭州微致生物科技有限公司 一株抗幽门螺杆菌的凝结魏茨曼氏菌vb320及其应用与培养装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11124368A (ja) * 1997-10-22 1999-05-11 Takeda Chem Ind Ltd 生理活性物質、その製造法及び剤
JP4541662B2 (ja) * 2003-05-29 2010-09-08 オリザ油化株式会社 抗ピロリ菌組成物
JP2006111573A (ja) * 2004-10-14 2006-04-27 Ee H C:Kk バチルス・サブチルス菌株の使用及びその使用に用いられる菌株を含む食品
CN101209271B (zh) * 2006-12-29 2011-06-22 江苏正大天晴药业股份有限公司 一种抗幽门螺杆菌的药物组合物
JP5794754B2 (ja) * 2009-03-31 2015-10-14 小林製薬株式会社 乳酸菌含有抗ヘリコバクター・ピロリ活性を有する経口剤
CN103565848B (zh) 2013-03-19 2017-02-08 青岛东海药业有限公司 凝结芽孢杆菌在制备预防和治疗幽门螺杆菌感染制剂中的应用

Also Published As

Publication number Publication date
JP2020521814A (ja) 2020-07-27
WO2018226781A1 (en) 2018-12-13
EP3634444B1 (en) 2023-08-16
EP3634444A4 (en) 2021-03-03
CA3061613A1 (en) 2018-12-13
AU2018281141A1 (en) 2019-10-31
JP6839329B2 (ja) 2021-03-03
KR102403453B1 (ko) 2022-05-30
CA3061613C (en) 2023-06-13
ES2963171T3 (es) 2024-03-25
US10792295B2 (en) 2020-10-06
US20180344754A1 (en) 2018-12-06
AU2018281141B2 (en) 2022-03-17
KR20190138823A (ko) 2019-12-16
AU2018281141A8 (en) 2019-11-21
EP3634444A1 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
IL268406A (en) Preparations and methods for treating hemoglobin diseases
IL260257A (en) Preparations and methods for the treatment of hemoglobinopathies
ZA202003849B (en) Vcar compositions and methods for use
IL261714A (en) Crispr/cas-related methods and preparations for treating diseases in the hemoglobin cell
GB201914076D0 (en) Methods and compositions for enhancing health
IL256621A (en) Carrier-binder preparations and methods for their preparation and use
ZA201900960B (en) Methods and compositions for the treatment of cancer
PL3524255T3 (pl) Kompozycja do leczenia trądziku
IL240387A0 (en) Pharmaceutical preparations for the treatment of Helicobacter pylori
LT4101454T (lt) Kompozicijos, skirtos naudoti hipertenzijos gydymui
IL265791A (en) Compositions and methods for treating dry mouth
IL274524A (en) Preparations and methods for aquaculture
IL263793A (en) Compounds and preparations for the treatment of cancer
ZA201808232B (en) Compositions and methods for the treatment of cancer
IL269743A (en) Methods and preparations for the treatment of disease related to the retina with CCR-3 inhibitor inventions
LT3373922T (lt) Kompozicijos ir būdai skirti naudoti homocistinurijos gydyme
GB201614961D0 (en) Compounds and compositions for use
SG11202000724XA (en) Methods and compositions for the treatment of cancer
PT3548006T (pt) Composição para utilização no tratamento de alterações intestinais
GB201911959D0 (en) Immunogenic compositions and uses therefor
SG11201706369PA (en) Compositions and methods for the treatment of mucositis
SG11202004167XA (en) Immunogenic compositions and uses therefor
GB201521083D0 (en) Compositions for treatment and methods thereof